Recent searches
Search options
After January's FLiRT soup (JN.1 and JN.1.11 lineages vying for dominance), we've returned to JN.1.11 soup (FLiRT and FLuQE clusters competing), that began when FLuQE majority ended in November.
After no data two weeks ago, #CDC updated variant estimates.
Raj has updated dashboard Sunday with new GISAID sequences. As of data two weeks ago, XEC.8 joins XEC.2 and LP.8.1.1 / NY as significant.
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis
![Chart: Estimated U.S. Variant Proportions by Common Name
Sources: Centers for Disease Control, CoV-Lineages, NYITCOM Research, Daniele Focosi, World Health Network, others
[ beadsland on Ko-fi ]
Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.
Five bar-style tree-charts, for fortnights through February 2–15. Legend of last fortnight, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.
Essentially all WHO-Vaccine-Target JN.1. JN.1.11 accounts for over half; JN.1 + FLiRT for near half.
For fortnight of 1/19–2/1, packed bubble charts fill single-variant tiles, indicating diversification of those variants (per GISAID) that wouldn't otherwise be apparent from CDC's Nowcast.
Legend:
XEC [reds]:
37% - XEC.2†, XEC.8† & other XEC
4% - XEC.4
JN.1.11 + FLiRT [browns]:
31% - LP.8.1.1 / NY† & other LP.8.1
1% - XEK
⅒% - KP.2.3, FDA-Vaccine-Target KP.2 & KP.1.1.3 / LP
JN.1.11 + FLuQE [greens]:
3% - XEQ
17% - MC.10.1, MC.1, MC.19 & other KP.3.1.1 / MC
⅗% - other KP.3
JN.1 + FLiRT [blues]:
3% - LF.7
2% - LB.1.3.1 / NL
0% - LB.1
JN.1 + FLiRT-KS [purple]:
⅒% - other KS.1
Other [greys]:
½% - JN.1.16
⅓% - other Pirola BA.2.86
⅒% - Other (not specified)
† Dagger variants are not broken out by CDC, yet represent a significant share of recent GISAID sequences.](https://spaces.hcommons.social/media_attachments/files/114/027/716/813/926/890/original/6403b3cd89efd3c3.jpg "Chart: Estimated U.S. Variant Proportions by Common Name
Sources: Centers for Disease Control, CoV-Lineages, NYITCOM Research, Daniele Focosi, World Health Network, others
[ beadsland on Ko-fi ]
Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.
Five bar-style tree-charts, for fortnights through February 2–15. Legend of last fortnight, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.
Essentially all WHO-Vaccine-Target JN.1. JN.1.11 accounts for over half; JN.1 + FLiRT for near half.
For fortnight of 1/19–2/1, packed bubble charts fill single-variant tiles, indicating diversification of those variants (per GISAID) that wouldn't otherwise be apparent from CDC's Nowcast.
Legend:
XEC [reds]:
37% - XEC.2†, XEC.8† & other XEC
4% - XEC.4
JN.1.11 + FLiRT [browns]:
31% - LP.8.1.1 / NY† & other LP.8.1
1% - XEK
⅒% - KP.2.3, FDA-Vaccine-Target KP.2 & KP.1.1.3 / LP
JN.1.11 + FLuQE [greens]:
3% - XEQ
17% - MC.10.1, MC.1, MC.19 & other KP.3.1.1 / MC
⅗% - other KP.3
JN.1 + FLiRT [blues]:
3% - LF.7
2% - LB.1.3.1 / NL
0% - LB.1
JN.1 + FLiRT-KS [purple]:
⅒% - other KS.1
Other [greys]:
½% - JN.1.16
⅓% - other Pirola BA.2.86
⅒% - Other (not specified)
† Dagger variants are not broken out by CDC, yet represent a significant share of recent GISAID sequences.")
ALT